Follow Healthline   |   Healthline on TwitterTwitter   |   Healthline on FacebookFacebook
Symptom Search   |   Treatment Search   |   Doctor Search   |   Drug Search

Drug Notebook

Generic Name: ketorolac

View All Brands
Ketorolac Tromethamine Novaplus, Toradol, Toradol IV/IM, Ketorolac Tromethamine, Toradol IM
An NSAID - It is used for a short while to treat moderate to severe pain, including pain after surge... more
Search Drug Notebook
Hide
Your search results:
Search the ketorolac Drug Notebook
FDA Alerts

    Appropriate Use
  • Indicated for short-term (≤5 days in adults) management of moderately severe acute pain that requires analgesia at opiate level. Not indicated for use in minor or chronic painful conditions.
  • A potent NSAIA; administration associated with risks. Serious NSAIA-related adverse effects can occur in patients in whom the drug is indicated, especially when the drug is used inappropriately. Increasing the dose beyond the recommended dose will not result in improved efficacy and increases the risk of serious adverse effects.

    GI Effects
  • Can cause peptic ulcers, GI bleeding, and/or perforation. Contraindicated in patients with active peptic ulcer disease, recent GI bleeding or perforation, or a history of peptic ulcer disease or GI bleeding.
  • Serious GI events can occur at any time and may not be preceded by warning signs and symptoms. Geriatric individuals are at greater risk for serious GI events. (See GI Effects under Cautions.)

    Renal Effects
  • Contraindicated in patients with advanced renal impairment and those at risk of renal failure because of volume depletion.

    Hematologic Effects
  • Inhibits platelet function. Contraindicated in patients with suspected or confirmed cerebrovascular bleeding, hemorrhagic diathesis, or incomplete hemostasis and in patients at a high risk of bleeding.
  • Contraindicated as prophylactic analgesic before major surgery; contraindicated as intraoperative analgesic during procedures where hemostasis is critical. Increased risk of bleeding in these patients.

    Cardiovascular Risk
  • Contraindicated for the treatment of pain in the setting of CABG surgery.
  • Possible increased risk of serious (sometimes fatal) cardiovascular thrombotic events (e.g., MI, stroke). Risk may increase with duration of use. Individuals with cardiovascular disease or risk factors for cardiovascular disease may be at increased risk. (See Cardiovascular Effects under Cautions.)

    Sensitivity Reactions
  • Hypersensitivity reactions (e.g., bronchospasm, anaphylactic shock) reported; appropriate counteractive measures must be available when administering the first dose. Contraindicated in patients with known hypersensitivity to ketorolac, aspirin, or other NSAIAs.

    Intrathecal or Epidural Administration
  • Contraindicated for intrathecal or epidural administration because of alcohol content in parenteral formulation.

    Labor and Delivery
  • Contraindicated during labor and delivery. (See Pregnancy under Cautions.)

    Lactation
  • Contraindicated in nursing women.

    Concomitant Use with NSAIAs
  • Contraindicated in patients receiving aspirin or other NSAIAs because of cumulative risk of serious adverse effects.

    Dosage and Administration
  • Oral formulation is used as continuation therapy in adults; total combined duration of parenteral and oral therapy in adults should not exceed 5 days because of increased risk of serious adverse effects.
  • Maximum daily oral dosage (40 mg) is lower than the maximum daily parenteral dosage (120 mg).

    Special Populations
  • Adjust dosage in patients ≥65 years of age, adults weighing <50 kg, and those with moderately increased Scr. Daily parenteral dosage should not exceed 60 mg in these patients. (See Dosage and Administration.)
  • Administer only a single parenteral dose in children; maximum 30 mg IM or 15 mg IV.

Media Gallery
Drug Info Tools
Search by color, shape and markings. click here
Check any 2 drugs for interactions. click here
Compare any two drugs side by side. click here
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
Advertisement
Marketplace
ketorolac
(kee toe ROLE ak)
301 / ETHEX | 10 mg301 / ETHEX   10 mg
bottle, 100 each Ketorolac Tromethamine 10mg, Oral tablet, white, round-shaped, side 1:301, side 2:ETHEX
M 134 | 10 mgM 134   10 mg
bottle, 4 each Ketorolac Tromethamine 10mg, Oral tablet, white, round-shaped, side 1:M 134
M 134 | 10 mgM 134   10 mg
bottle, 100 each Ketorolac Tromethamine 10mg, Oral tablet, white, round-shaped, side 1:M 134
93 / 314 | 10 mg93 / 314   10 mg
bottle, 100 each Ketorolac Tromethamine 10mg, Oral tablet, white, round-shaped, side 1:93, side 2:314
T TORADOL / T ROCHE | 10 mgT TORADOL / T ROCHE   10 mg
bottle, 100 each Ketorolac Tromethamine 10mg, Oral tablet, white, round-shaped, side 1:T TORADOL, side 2:T ROCHE
T ROCHE / T TORADOL | 10 mgT ROCHE / T TORADOL   10 mg
bottle, 8 each Ketorolac Tromethamine 10mg, Oral tablet, white, round-shaped, side 1:T ROCHE, side 2:T TORADOL
Back to Top